International Journal of Hematology

Article	Citations
Obituary of Professor Fumimaro Takaku: a tribute to a real leader in medicine in Japan (1931–2022)	65
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria	63
Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes	38
Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation	37
Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/β-thalassemia and those achieving successful hematopoietic stem-cell transplantation	28
Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease	27
Chronic active Epstein–Barr virus infection presenting as refractory chronic sinusitis	23
Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study	21
Decreased incidence of acute immune thrombocytopenia in children during the COVID-19 pandemic	20
Acquired hypofibrinogenemia in a patient with multiple myeloma	19
Treatment options and pregnancy management for patients with PV and ET	19
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era	18
EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells	18
In memory of Prof. Minoru Okuma	17
Long-term retrospective study of retinoic acid combined with arsenic and chemotherapy for acute promyelocytic leukemia	17
NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein–Barr virus infection	17
Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemia	16
Peritoneal lymphomatosis with CD5-positive diffuse large B-cell lymphoma	16
Engraftment outcome of patients with anti-HLA antibodies in HLA-mismatched peripheral blood stem cell transplantation	16
Correction: Real‑world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis o	16
Isatuximab plus pomalidomide and dexamethasone in frail individuals with relapsed/refractory multiple myeloma in Japan	16
Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era	15
Incidence of venous thromboembolism in patients with solid cancers in Japan: retrospective study of 2735 patients	15
Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden	15
Lethal macrophage-related complications of juvenile myelomonocytic leukemia with a blastic crisis: an autopsy case report	14

Increased serum C-reactive protein is an adverse prognostic factor in low-risk myelodysplastic syndromes	14
Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance	13
Light chain proximal tubulopathy diagnosed solely by electron microscopy of a renal biopsy specimen in a patient with monoclonal gammopathy of undetermined significance	13
Assessment of cellular response to mitogens in long-term allogeneic hematopoietic stem cell transplantation survivors	13
Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia	13
Retrospective comparison of reinfusion procedures and subsequent leukopenia in autologous stem cell transplantation	13
Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan	12
Hematopoietic cell transplantation for mantle cell lymphoma	12
Epstein-Barr virus-related lymphoproliferative disorders in T-cell repleted haploidentical transplantation with post-transplant cyclophosphamide	12
A retrospective single-center analysis of G-CSF-mobilized donor lymphocyte infusion in hematologic malignancies after unmanipulated allogenic PBSCT	12
A case of multiple brain abscesses due to Bacillus cereus during induction therapy for acute myeloid leukemia	12
Prevention of acute graft-versus-host disease in adult T-cell leukemia–lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation	12
Anti-Fya-mediated delayed hemolytic transfusion reaction following emergency-release red blood cell transfusion: possible involvement of HLA-DRB1*04:03 in the Japanese population	12
Hemophilic pseudotumor of the maxillary sinus in an inhibitor-positive patient with hemophilia A receiving emicizumab: a case report	11
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan	11
Clinical, laboratory, and mutational profile of children with glucose phosphate isomerase deficiency: a single centre report	11
Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development	11
A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia	10
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan	10
The safety and efficacy of hematopoietic stem cell mobilization using biosimilar filgrastim in related donors	10
Bosutinib-induced lung injury: a report of two cases and literature review	10
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation	10
First reported case of splenic diffuse red pulp small B-cell lymphoma with novel mutations in CXCR4 and TRAF3 genes	10
Antibody response to COVID-19 vaccination in patients with lymphoma	10
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy	10
JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML)	10
Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors	9
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia	9
A review of the Augustine blood group system	9
Reply to the Dr. Murphy’s comment	9
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study	9
GPS2 promotes erythroid differentiation in K562 erythroleukemia cells primarily via NCOR1	9
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia	9
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study	9
Misleading antigenic von Willebrand factor levels in acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance	9
Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect	9
Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples	9
Carcinocythemia diagnosed on peripheral blood clot sections	8
Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis	8
Treatment-related sequelae in Hodgkin’s lymphoma after mediastinal irradiation	8
Bringing mass spectrometry into the care of patients with multiple myeloma	8
Impact of stem cell source on secondary steroid for chronic GVHD after allogeneic hematopoietic cell transplantation	8
Acute myeloid leukemia with NUP98::RARG rearrangement: a case report and review of the relevant literature	8
Nivolumab-induced systemic lymphadenopathy occurring during treatment of malignant melanoma: a case report	8
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody	8
A lower initial dose of bosutinib for patients with chronic myeloid leukemia patients resistant and/or intolerant to prior therapy: a single-arm, multicenter, phase 2 trial (BOGI trial)	8
Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias treated with azacitidine	8
Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial	8
JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia	8
Risk factors for unplanned removal of central venous catheters in hospitalized children with hematological and oncological disorders	7

Anakinra for the treatment of adult secondary HLH: a retrospective experience	7
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia	7
Adverse impact of a high allelic burden FLT3-ITD mutation on allogeneic hematopoietic stem cell transplantation in patients with cytogenetically normal AML	7
Factor XII deficiency: a clinical and molecular genetic study	7
Bilateral adrenal hemorrhage: a rare presentation of acute myeloid leukemia	7
Conditioning regimens for inborn errors of immunity: current perspectives and future strategies	7
Septic shock caused by Capnocytophaga canimorsus in a patient with heterozygous Pelger-Huët anomaly	7
Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma	7
Clinical characteristics of steroid-responsive but dependent chronic graft-versus-host disease: a multicenter retrospective analysis	7
Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter study	7
NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia	7
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice	7
Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study	7
Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease	7
Modified expi293 cell culture system using piggyBac transposon enables efficient production of human FVIII	7
Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan	7
Unilateral recurrent laryngeal nerve palsy detected by PET/CT in a patient with mediastinal T-cell lymphoblastic lymphoma	7
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets	6
Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis	6
Human leukocyte antigen 7/8-matched unrelated bone marrow transplantation using anti-thymocyte globulin in children	6
A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation	6
Successful allogeneic hematopoietic stem cell transplantation in a patient with type I CD36 deficiency: a case study and literature review	6
New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination	6
Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment	6
Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells	6
A case of neurodegenerative Langerhans cell histiocytosis exhibiting high osteopontin in cerebrospinal fluid without specific radiological abnormalities	6
Histopathological maturation in juvenile xanthogranuloma: a blueberry muffin infant mimicking aleukemic leukemia cutis	6
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib	6
T cell lymphoma: time to make discoveries and advance treatment	6
Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases	6
Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice	6
Chronic neutrophilic leukemia preceded by myelodysplastic syndromes	6
Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation	6
Stem cell regulation and dynamics in myeloid malignancies	6
Isolated thrombosis after COVID-19 vaccination: case series	5
Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide	5
Evolution of natural killer cell-targeted therapy for acute myeloid leukemia	5
Post-transfusion purpura and adult primary thrombocytopenia	5
Biological and clinical significance of epigenetic alterations in B-cell lymphomas	5
Honeycomb lung appearance accompanied by pediatric Langerhans cell histiocytosis: changes in imaging findings following chemotherapy	5
Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience	5
Aortitis after administration of pegfilgrastim to a healthy donor for peripheral blood stem cell collection	5
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan	5
Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma	5
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment	5
Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in Japan	5
The role of epigenetics in T-cell lymphoma	5
Long-term lymphocyte subset number reconstitution is unique but comparable between umbilical cord blood and unrelated bone marrow transplantation	5
Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapy	5
Correction to: Irradiation induces homing of donor endothelial progenitor cells in allogeneic hematopoietic stem cell transplantation	5
Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia	5
A case of acute lung injury in a peripheral blood stem cell donor mobilized with pegylated recombinant human granulocyte colony-stimulating factor	5
Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma	5
Correction: Moving towards biologically informed treatment strategies for T-cell lymphomas	5
Clinical guidelines for prevention and treatment of CAT in Japan and other countries	5
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment	5
Effects of tucidinostat in adult T-cell leukemia/lymphoma in clinical practice	5
Severe systemic inflammation mimicking TAFRO syndrome following COVID-19	5
Practical management of patients with hematological diseases during the COVID-19 pandemic in Japan	5
Late-onset radiation necrosis of the larynx attributed to hydroxyurea taken for essential thrombocythemia	5
Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma	5
Phase 2 multicenter study of pegaspargase in Japanese patients with previously untreated acute lymphoblastic leukemia	5
Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series	5
Oral beclomethasone dipropionate therapy and prognostic plasma biomarkers for gastrointestinal graft-versus-host disease	5
Protection from bleeds during physical activity in people with haemophilia: the role of factor levels: a response to Nogami et al. (2023)	5
Incidence trends for common subtypes of T-cell lymphoma in Taiwan and the United States from 2008–2020	5
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021)	5
Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis	5
Cancer-associated thrombosis in hematologic malignancies	5
Cancer-associated thrombosis and bleeding	5
Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL	5
Primary pancreatic diffuse large B-cell lymphoma, appearing as an asymptomatic bulky mass with the duct-penetrating sign	5
Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia	5
ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial	4
Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation	4
JSH practical guidelines for hematological malignancies, 2023: leukemia-5. Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)	4
CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence	4
Stopping bosutinib reverses bosutinib-induced elevation of serum creatinine in patients with chronic myeloid leukemia	4
Prognostic impact of effusion in multiple body cavities after allogeneic hematopoietic stem cell transplantation	4
Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study	4

Successful preventive treatment with cyclosporine in a patient with relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a case report and review of the literature	4
Impact of muscle loss in children with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation	4
Some key considerations regarding the design and evaluation of high-throughput sequencing-based biallelic chimerism assays	4
Clinical significance of human endogenous retrovirus K (HERV-K) in multiple myeloma progression	4
Simultaneous diagnosis of plasma cell myeloma and chronic lymphocytic leukemia on bone marrow trephine biopsy	4
Multifocal osteonecrosis after stem cell transplantation	4
Clinical impacts of frailty, poor performance status, and advanced age in carfilzomib-containing treatment for relapsed/refractory multiple myeloma: post hoc investigation of the KOTOSG multicenter pi	4
Correction: Raising awareness may increase the likelihood of hematopoietic stem cell donation: a nationwide survey using artificial intelligence	4
Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial	4
Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma	4
Guest editorial: current status and future perspectives of allogeneic hematopoietic cell transplantation for non-malignant diseases	4
Clostridium septicum myonecrosis following chemotherapy	4
Armor sign on PET–CT in a young male with non-Hodgkin’s lymphoma	4
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line	4
Three atypical BCR/ABL transcripts detected simultaneously in a Philadelphia-positive acute lymphoblastic leukemia patient showing resistance to tyrosine kinase inhibitors	4
Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1	4
Guest editorial: prophylaxis and treatment of relapse after allogeneic hematopoietic stem cell transplantation	4
Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in c	4
Unresolved issues in allogeneic hematopoietic cell transplantation for non-malignant diseases	4
Increasing numbers of CD19 + CD24highCD38high regulatory B cells and pre-germinal center B cells reflect activated autoimmunity and predict future treatment response in patients with untreated immune	4
Concomitant letermovir affects the optimal concentration-to-dose ratio of tacrolimus after switching from intravenous to oral tacrolimus administration in hematopoietic cell transplantation patients r	4
Reduced incidence of hemophagocytic lymphohistiocytosis in Japan during the COVID-19 pandemic	4
Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases	4
Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva	4
C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis	4
Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma	4
A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis	4
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study	4
Asciminib as a third line option in chronic myeloid leukemia	4
Endothelial function testing before conditioning therapy is useful for predicting transplant-related complications after allogeneic hematopoietic cell transplantation	4
Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial	3
Epigenetics in lymphocyte and lymphoma: EZH2 as an easy-to-access therapeutic target?	3
Ribosome profiling analysis reveals the roles of DDX41 in translational regulation	3
Development of CMV-CD19 bi-specific CAR T cells with post-infusion in vivo boost using an anti-CMV vaccine	3
Efficacy and safety of bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia in the Asian subpopulation of the phase 3 BFORE trial	3
The Nup98::Nsd1 fusion gene induces CD123 expression in 32D cells	3
Recent progress in ITP treatment	3
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)	3
Characteristic and recurrent pathophysiological features of non-duodenal follicular lymphoma of the small intestine	3
HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA	3
Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipi	3
Vedolizumab for children with intestinal graft-versus-host disease: a case report and literature review	3
Novel treatment strategies for hematological malignancies in the immunotherapy era	3
Molecular pathophysiology of germline mutations in acute myeloid leukemia	3
Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome	3
Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome	3
Rivaroxaban for severe superior sagittal sinus thrombosis in a child with ALL	3
Mycobacterial lymphadenitis without granuloma formation in a patient with anti-interferon-gamma antibodies	3
Cytomegalovirus-induced stomatitis in a patient with refractory diffuse large B-cell lymphoma	3
Refractory T-cell/histiocyte-rich large B-cell lymphoma in a patient with ataxia–telangiectasia caused by novel compound heterozygous variants in ATM	3
High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials	3
Incidence and risk factors of late-onset hemorrhagic cystitis after single umbilical cord blood transplantation with myeloablative conditioning regimen	3
Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation	3
Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease	3
Transcriptome sequencing identifies novel EVX fusions involved in transcriptional activation of HOX family genes in pediatric immature T-cell acute lymphoblastic leukemia: two cases reports and a lite	3
Correction: JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML)	3
Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum	3
Vitamin B12 deficiency-induced megaloblastic anemia in a pediatric patient with autism spectrum disorder with a chronically unbalanced diet	3
Isolated salivary gland extramedullary relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia during blinatumomab treatment	3
CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicity	3
Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial	3
Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus	3
Early chemotherapeutic intervention to avoid thyroidectomy in pediatric Langerhans cell histiocytosis with thyroid involvement accompanying tracheal stenosis: a report of two cases	3
Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a	3
Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR us	3
Outcome of hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia not in remission enrolled in JACLS ALL-02	3
Reference intervals of red blood cell parameters and platelet count for healthy adults in Japan	3
Frequency and driver mutation diversity of concomitant chronic myeloid leukemia and Philadelphia chromosome-negative myeloproliferative neoplasm	3
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study	3
Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)	3
Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors	3
Adult-onset severe paroxysmal cold hemoglobinuria after COVID-19 successfully treated with sutimlimab	3
Splenectomy as an effective treatment for macrothrombocytopenia in Takenouchi-Kosaki syndrome	3
Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation	3
A case report of a truncated ABL1 mutation in 2 cases with Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia	3
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation	3
Correction to: Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study	3
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia	3
JSH practical guidelines for hematological malignancies, 2023: leukemia-3. Acute lymphoblastic leukemia/lymphoblastic lymphoma: ALL/LBL	3
Effectiveness of venetoclax and azacytidine against myeloid/natural killer cell precursor acute leukemia	3
Long-range and real-time PCR identification of a large SERPINC1 deletion in a patient with antithrombin deficiency	3
Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A	3
Association of depression and social anxiety symptom scores with disease characteristics in pediatric patients with chronic immune thrombocytopenia: a cross-sectional study	3
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors	3
Non-age-related neoplastic loss of sex chromosome correlated with prolonged survival in real-world CBF-AML patients	3
Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation	3
Blasts engulfing erythrocytes: an unusual morphological finding in adult early T-precursor acute lymphoblastic leukemia	3
Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II	3
Identification of a novel mutation in the factor XIII A subunit in a patient with inherited factor XIII deficiency	3
Expression of activated integrin β7 in multiple myeloma patients	3
Diagnosis of immune pathophysiology in patients with bone marrow failure	3